Selank
Selank is a synthetic heptapeptide analogue of the human tetrapeptide Tuftsin, developed in Russia. It has been studied for its anxiolytic (anti-anxiety) and nootropic effects, and is approved as a medication in Russia.
Quick facts
- Half-life
- ~1–2 minutes (rapidly metabolised)
- Administration
- Nasal spray / Subcutaneous injection
- Primary use
- Anxiety reduction, cognitive enhancement
How it works
Selank modulates the expression of brain-derived neurotrophic factor (BDNF) and influences the GABAergic system, producing anxiolytic effects without sedation. It also appears to regulate serotonin and dopamine metabolism.
Reported benefits
- Reduced anxiety without sedation or dependence
- Improved focus, memory, and learning capacity
- Mood stabilisation and stress resilience
- Immune system modulation
Typical dosing protocol
Dosing
250–3000 mcg per day via nasal spray, or 250–500 mcg subcutaneously
Cycle length
2–4 weeks, with breaks
Dosing information is for educational reference only. Individual needs vary. Always consult a healthcare professional.
Safety & considerations
Well-tolerated in clinical studies. Not approved for human use in the UK. Approved as a medication in Russia. Consult a healthcare professional before use.
Important: All content is for informational purposes only. Not medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.